Concentric Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,212
Closed -$815K 129
2019
Q3
$815K Sell
8,212
-120
-1% -$11.4K 0.52% 55
2019
Q2
$770K Hold
8,332
0.5% 56
2019
Q1
$786K Buy
8,332
+130
+2% +$11.4K 0.53% 55
2018
Q4
$526K Sell
8,202
-5,496
-40% -$406K 0.4% 60
2018
Q3
$1.23M Buy
13,698
+592
+5% +$52.3K 0.86% 50
2018
Q2
$1.04M Buy
13,106
+190
+1% +$15.8K 0.75% 54
2018
Q1
$1.15M Buy
12,916
+740
+6% +$71K 0.85% 51
2017
Q4
$1.27M Buy
12,176
+785
+7% +$88.6K 0.92% 48
2017
Q3
$1.66M Buy
11,391
+160
+1% +$21.8K 1.26% 34
2017
Q2
$1.46M Buy
11,231
+60
+0.5% +$7.35K 1.16% 39
2017
Q1
$1.39M Buy
11,171
+78
+0.7% +$9.33K 1.13% 40
2016
Q4
$1.28M Buy
+11,093
New +$1.24M 1.08% 42

Other funds holding CELG

Concentric Wealth Management's CELG Position: Q4 2019 in Review

Concentric Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,212 shares — an estimated $815K sold.

Concentric Wealth Management first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $1.66M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Concentric Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Concentric Wealth Management sold 8,212 Celgene Corp shares in Q4 2019, an estimated $815K.
  • Concentric Wealth Management first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • Concentric Wealth Management's Celgene Corp position peaked at $1.66M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Concentric Wealth Management's 13F filing for Q4 2019, filed 10 Feb 2020.